Evidence map›Paper›PMID 42440489›Full record

ArticleFrontiers in immunology2026

HBV pgRNA induces chronic inflammation in an IL-1β-dependent manner.

Aikaterini Skeva, Konstantinos Marmanis, Maria Ntinopoulou, Panagiotis Liakopoulos, Eleni Tryfonopoulou, Anna Chalkidou, Stella Arelaki, Katerina Chlichlia, Maria Koffa, Akrivi Chrysanthopoulou and 5 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Aikaterini SkevaLaboratory of Microbiology, Department of Medicine, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
Konstantinos MarmanisLaboratory of Cellular and Molecular Biology, Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
Maria NtinopoulouLaboratory of Molecular Immunology, Department of Biological Applications and Technology, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Panagiotis LiakopoulosDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, Dragana, Alexandroupolis, Greece.
Eleni TryfonopoulouLaboratory of Molecular Immunobiology, Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
Anna Chalkidou2nd Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Stella ArelakiLaboratory of Pathology, Democritus University of Thrace, Alexandroupolis, Greece.
Katerina ChlichliaLaboratory of Molecular Immunobiology, Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
Maria KoffaLaboratory of Cellular and Molecular Biology, Department of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
Akrivi ChrysanthopoulouLaboratory of Molecular Immunology, Department of Biological Applications and Technology, School of Health Sciences, University of Ioannina, Ioannina, Greece.
Petros KolovosDepartment of Molecular Biology and Genetics, School of Health Sciences, Democritus University of Thrace, Dragana, Alexandroupolis, Greece.
Alexandra GiatromanolakiLaboratory of Pathology, Democritus University of Thrace, Alexandroupolis, Greece.
Konstantinos Mimidis1st Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece.
Theocharis G Konstantinidis *Laboratory of Microbiology, Department of Medicine, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.
Maria Panopoulou *Laboratory of Microbiology, Department of Medicine, School of Health Sciences, Democritus University of Thrace, Alexandroupolis, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Chronic hepatitis B (CHB) is a widespread form of hepatitis B infection with advanced complications if unsupervised and untreated. It was previously reported that pregenomic RNA (pgRNA) can be detected in blood circulation as an indirect marker of HBV transcriptional activity. The aim of this study was to investigate the transcriptomic profile of pgRNA-positive patients with CHB in comparison to pgRNA-negative patients and to evaluate its role in innate immunity. Materials and methods: A total of 88 patients with CHB who were receiving nucleoside analogs (NAs) were enrolled in this study. The viral load and genotype, HBV pgRNA, and biochemical and virological markers were determined. Samples from eight CHB HBeAg-negative patients were sequenced. Four of them were positive for HBV pgRNA, while the rest were negative. These data were processed via bioinformatic tools. Bioinformatic analyses revealed common pathways such as platelet activation and neutrophil degranulation, for which experimental setups were organized. Platelet activation, as well as platelet-neutrophil interactions, was examined. Furthermore, the synthesis and expression of interleukins IL-1β, IL-17A, and LL-37 were studied. Results: The percentage of patients positive for HBV pgRNA in the study population was 18.1%. With respect to the transcriptomic analysis, which was performed via two distinct analyses, we identified common differentially expressed (DE) genes involved in platelet activation and neutrophil degranulation pathways. Afterwards, the induction of autophagy in platelets and the Conclusions: This study demonstrated that HBV pgRNA activates platelets in an autophagy-dependent manner. Moreover, the platelet-neutrophil axis is responsible for a proinflammatory phenotype in which IL-1β is overexpressed.

Indexed as

Hepatitis B, ChronicHepatitis B virusInflammationInterleukin-1betaRNA, ViralAdultBlood PlateletsFemaleGene Expression ProfilingHumansImmunity, InnateMaleMiddle AgedNeutrophilsPlatelet ActivationViral LoadInterleukin-1betaRNA, Viralchronic hepatitis Bchronic inflammationHBeAg negativeinterleukin-1b (IL-1β)LL-37pregenomic RNA

Identifiers

PMID42440489
PMCPMC13333505

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.